Medtronic plc MDT
$91.27
+0.76%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (15 Buy · 6 Hold · 0 Sell)
- Average Price Target
- $101.90
- Implied Upside
- +11.6%
- Price Target Range
- $83.00 – $120.00
- Analysts (12 mo)
- 21
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-28 | UBSPriya Sachdeva |
Upgrades | Neutral → Buy | $85 → $100 |
| 2026-07-10 | TD CowenJoshua Jennings |
Maintains | Buy | $119 → $100 |
| 2026-07-06 | Evercore ISI GroupVijay Kumar |
Maintains | Outperform | $106 → $105 |
| 2026-06-17 | NeedhamMike Matson |
Reiterates | Buy | $101 |
| 2026-06-05 | Goldman SachsDavid Roman |
Maintains | Neutral | $84 → $83 |
| 2026-06-05 | BernsteinLee Hambright |
Maintains | Outperform | $112 → $97 |
| 2026-06-04 | UBSPriya Sachdeva |
Maintains | Neutral | $90 → $85 |
| 2026-06-04 | TD CowenJoshua Jennings |
Reiterates | Buy | $119 |
| 2026-06-04 | RBC CapitalShagun Singh |
Reiterates | Outperform | $118 |
| 2026-06-04 | Wells FargoLarry Biegelsen |
Maintains | Overweight | $114 → $102 |
| 2026-06-04 | Leerink PartnersMike Kratky |
Maintains | Outperform | $117 → $104 |
| 2026-06-04 | BairdDavid Rescott |
Maintains | Neutral | $93 → $85 |
| 2026-06-04 | BTIGRyan Zimmerman |
Upgrades | Neutral → Buy | $90 |
| 2026-06-03 | MizuhoAnthony Petrone |
Maintains | Outperform | $120 → $100 |
| 2026-06-03 | NeedhamMike Matson |
Maintains | Buy | $120 → $101 |
| 2026-04-22 | UBSPriya Sachdeva |
Maintains | Neutral | $104 → $90 |
| 2026-04-15 | Truist SecuritiesRichard Newitter |
Maintains | Hold | $103 → $95 |
| 2026-04-13 | MizuhoAnthony Petrone |
Maintains | Outperform | $125 → $120 |
| 2026-04-09 | Evercore ISI GroupVijay Kumar |
Maintains | Outperform | $108 → $106 |
| 2026-04-07 | CitigroupJoanne Wuensch |
Maintains | Buy | $117 → $110 |
| 2026-04-06 | Evercore ISI GroupVijay Kumar |
Maintains | Outperform | $115 → $108 |
| 2026-04-06 | Argus ResearchDavid Toung |
Maintains | Buy | $125 → $115 |
| 2026-04-01 | BarclaysMatt Miksic |
Maintains | Overweight | $118 → $120 |
| 2026-04-01 | Piper SandlerMatt O'Brien |
Maintains | Neutral | $105 → $91 |
| 2026-03-26 | NeedhamMike Matson |
Reiterates | Buy | $120 |
| 2026-03-10 | NeedhamMike Matson |
Reiterates | Buy | $120 |
| 2026-02-18 | JP MorganRobbie Marcus |
Maintains | Neutral | $105 → $100 |
| 2026-02-18 | BarclaysMatt Miksic |
Maintains | Overweight | $116 → $118 |
| 2026-02-18 | BairdDavid Rescott |
Maintains | Neutral | $103 → $100 |
| 2026-02-17 | NeedhamMike Matson |
Maintains | Buy | $121 → $120 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $91.27
- Market Cap
- $116.18 billion
- 52-Week Range
- $73.31 – $106.33
- Average Volume
- 7.20 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.